2013 ESH/ESC Guidelines for the management of arterial hypertension
Top Cited Papers
Open Access
- 1 July 2013
- journal article
- practice guideline
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Hypertension
- Vol. 31 (7), 1281-1357
- https://doi.org/10.1097/01.hjh.0000431740.32696.cc
Abstract
Because of new evidence on several diagnostic and therapeutic aspects of hypertension, the present guidelines differ in many respects from the previous ones. Some of the most important differences are listed below: 1. Epidemiological data on hypertension and BP control in Europe. 2. Strengthening of the prognostic value of home blood pressure monitoring (HBPM) and of its role for diagnosis and management of hypertension, next to ambulatory blood pressure monitoring (ABPM). 3. Update of the prognostic significance of night-time BP, white-coat hypertension and masked hypertension. 4. Re-emphasis on integration of BP, cardiovascular (CV) risk factors, asymptomatic organ damage (OD) and clinical complications for total CV risk assessment. 5. Update of the prognostic significance of asymptomatic OD, including heart, blood vessels, kidney, eye and brain. 6. Reconsideration of the risk of overweight and target body mass index (BMI) in hypertension. 7. Hypertension in young people. 8. Initiation of antihypertensive treatment. More evidence-based criteria and no drug treatment of high normal BP. 9. Target BP for treatment. More evidence-based criteria and unified target systolic blood pressure (SBP) (<140 mmHg) in both higher and lower CV risk patients. 10. Liberal approach to initial monotherapy, without any all-ranking purpose. 11. Revised schema for priorital two-drug combinations. 12. New therapeutic algorithms for achieving target BP. 13. Extended section on therapeutic strategies in special conditions. 14. Revised recommendations on treatment of hypertension in the elderly. 15. Drug treatment of octogenarians. 16. Special attention to resistant hypertension and new treatment approaches. 17. Increased attention to OD-guided therapy. 18. New approaches to chronic management of hypertensive diseasKeywords
This publication has 661 references indexed in Scilit:
- Effectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in Women—2011 Update: A Guideline From the American Heart AssociationJournal of the American College of Cardiology, 2011
- Masked Hypertension: Evidence of the Need to TreatCurrent Hypertension Reports, 2010
- Tight Blood Pressure Control and Cardiovascular Outcomes Among Hypertensive Patients With Diabetes and Coronary Artery DiseaseJAMA, 2010
- β-Blockers May Reduce Mortality and Risk of Exacerbations in Patients With Chronic Obstructive Pulmonary DiseaseArchives of Internal Medicine, 2010
- Carotid Intima-Media Thickness and Presence or Absence of Plaque Improves Prediction of Coronary Heart Disease Risk: The ARIC (Atherosclerosis Risk In Communities) StudyJournal of the American College of Cardiology, 2010
- Effects of the DASH Diet Alone and in Combination With Exercise and Weight Loss on Blood Pressure and Cardiovascular Biomarkers in Men and Women With High Blood PressureJAMA Internal Medicine, 2010
- The Potency of Team-Based Care Interventions for HypertensionJAMA Internal Medicine, 2009
- Contraceptive Hormone Use and Cardiovascular DiseaseJournal of the American College of Cardiology, 2009
- Ankle Brachial Index Combined With Framingham Risk Score to Predict Cardiovascular Events and MortalityJAMA, 2008
- Characterization of Resistant HypertensionAssociation Between Resistant Hypertension, Aldosterone, and Persistent Intravascular Volume ExpansionJAMA Internal Medicine, 2008